SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-23-006959
Filing Date
2023-03-17
Accepted
2023-03-17 07:00:35
Documents
8
Period of Report
2023-05-17

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A dmtp20230313_pre14a.htm PRE 14A 857267
2 dmtp20230313_pre14aimg001.jpg GRAPHIC 5429
3 dmtp20230313_pre14aimg002.jpg GRAPHIC 2707
4 dmtp20230313_pre14aimg003.jpg GRAPHIC 6147
5 dmtp20230313_pre14aimg004.jpg GRAPHIC 19283
6 dmtp20230313_pre14aimg005.jpg GRAPHIC 1790
7 proxy01.jpg GRAPHIC 192533
8 proxy02.jpg GRAPHIC 216227
  Complete submission text file 0001437749-23-006959.txt   1470714
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36291 | Film No.: 23740650
SIC: 2834 Pharmaceutical Preparations